Testing still not complete on over half of backlogged rape kits that need to be tested
Schimel's failure to prioritize testing has delayed justice for survivors, while dangerous criminals remain on the streets
MADISON — Today, former federal prosecutor and candidate for Wisconsin Attorney General Josh Kaul released the following statement regarding Brad Schimel’s claims of success in addressing Wisconsin’s ongoing rape kit backlog.
“Despite today’s announcement, testing still hasn’t been completed on more than half of the kits in the rape-kit backlog that need to be tested. Brad Schimel’s failure to prioritize the elimination of the backlog has meant that justice has been delayed for survivors and that dangerous criminals have remained on the streets longer than they should have. Schimel should have made the elimination of the rape-kit backlog a priority as soon as he took office, but, instead, only nine of the kits in the backlog were tested in his first two years as AG.”
Josh Kaul served as a federal prosecutor in Baltimore, one of America’s most violent cities. There, Kaul prosecuted murderers, gang members, and drug traffickers, taking dangerous criminals off the street and making communities more secure. He grew up in Oshkosh and Fond du Lac in a family of law enforcement professionals and teachers. He is running for Attorney General in 2018.
For more information, please visit: www.joshkaul.org
Kaul for Attorney General
Recent Press Releases by Josh Kaul
Attorney General Kaul Joins Coalition of 23 Cities And States Suing Trump Administration To Stop Rule Allowing Discrimination in Providing Health CareMay 21st, 2019 by Josh Kaul
"The federal government shouldn’t be making it more difficult for patients to get needed health-care services."
Wisconsin’s lawsuit, filed in Dane County Circuit Court, seeks a permanent injunction, abatement of the public nuisance, and civil penalties.
AG Kaul Joins 44-State Coalition in Antitrust Lawsuit Against 20 Generic Drug Manufacturers for Conspiracy to Fix Prices and Allocate Markets for More Than 100 Different Generic DrugsMay 13th, 2019 by Josh Kaul
"The complaint in this case alleges wide-ranging anti-competitive conduct that resulted in inflated prices for prescription drugs."